- Home
- EDBL vs RDHL Comparison
EDBL vs RDHL Comparison
Compare EDBL & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- RDHL
- Stock Information
- Founded
- EDBL 2020
- RDHL 2009
- Country
- EDBL United States
- RDHL Israel
- Employees
- EDBL N/A
- RDHL N/A
- Industry
- EDBL Farming/Seeds/Milling
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- EDBL Consumer Staples
- RDHL Health Care
- Exchange
- EDBL Nasdaq
- RDHL Nasdaq
- Market Cap
- EDBL 4.8M
- RDHL 3.8M
- IPO Year
- EDBL 2022
- RDHL N/A
- Fundamental
- Price
- EDBL $2.60
- RDHL $1.85
- Analyst Decision
- EDBL
- RDHL
- Analyst Count
- EDBL 0
- RDHL 0
- Target Price
- EDBL N/A
- RDHL N/A
- AVG Volume (30 Days)
- EDBL 134.6K
- RDHL 18.5K
- Earning Date
- EDBL 08-13-2025
- RDHL 04-10-2025
- Dividend Yield
- EDBL N/A
- RDHL N/A
- EPS Growth
- EDBL N/A
- RDHL N/A
- EPS
- EDBL N/A
- RDHL N/A
- Revenue
- EDBL $13,443,000.00
- RDHL $8,042,999.00
- Revenue This Year
- EDBL $29.56
- RDHL $381.91
- Revenue Next Year
- EDBL $20.00
- RDHL N/A
- P/E Ratio
- EDBL N/A
- RDHL N/A
- Revenue Growth
- EDBL N/A
- RDHL 23.17
- 52 Week Low
- EDBL $1.80
- RDHL $1.71
- 52 Week High
- EDBL $39.50
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- EDBL 45.24
- RDHL 43.03
- Support Level
- EDBL $2.53
- RDHL $1.72
- Resistance Level
- EDBL $2.85
- RDHL $2.08
- Average True Range (ATR)
- EDBL 0.21
- RDHL 0.09
- MACD
- EDBL -0.06
- RDHL 0.01
- Stochastic Oscillator
- EDBL 16.18
- RDHL 27.78
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.